You are here :   Home     Food & Beverage     Food & Beverage Ingredients     Nutraceuticals     Omega 3 & structured lipids (Nutraceuticals)    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Asia-Pacific Omega 3 & structured lipids (Nutraceuticals) Market

  • Report Code: OM 1003
  • Publish Date: 17 Nov 2014
  • Next Update Date: 17 Feb 2015
Table of Contents
Customer Intelligence

Omega 3 & structured lipids (Nutraceuticals)-Asia-Pacific can be segmented by Companies, Applications and MacroIndicators. Companies of Omega 3 & structured lipids (Nutraceuticals)-Asia-Pacific are BASF Performance Products, DuPont Industrial biosciences, FMC Specialty Chemicals, ADM Oilseeds Processing, Cargill Incorporated, Ajinomoto Co., Inc. Pharmacueticals, Ingredion Incorporated, Roquette Pharma & Personal Care, Arla Group Food Ingredients, Royal DSM NV Pharma and Others(Company). Applications of Omega 3 & structured lipids (Nutraceuticals)-Asia-Pacific are Functional Food, Functional Beverages, Dietary Supplements, Animal Feed and Personal Care (Industry). MacroIndicators of Omega 3 & structured lipids (Nutraceuticals)-Asia-Pacific are Population Projection.


Customization Options:


MMM assessment can be customized to suit the specific requirements of your company. Customize the report to the get current industry benchmarks and in-depth study with respect to the following considerations:


Product Type Assistance

  • Review of the wide range of formulations of omega-3 and structured lipids
  • Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level.
  • Country-level analysis of the sub-types like Eicosapentaenoic acid (EPA), Docosahexaenoic acid(DHA), Alpha-Linolenic acid (ALA), Structured lipids, and other specialty fatty acids


Supply channel Analysis

  • Analysis & Identification of the evolving supply chain infrastructure
  • Procurement Opportunities & Challenges specific to this region
  • Analysis on raw material availability, pricing trends and distribution channels


Market Trends

  • Locating specific target markets within the region wherein maximum return on investment can be generated
  • Study of the clinical benefits of the omega-3 and structured lipids, particularly their exact role in neural and cardiovascular development.
  • Detailed analysis of the rapidly expanding functional beverages market, in which these ingredients play a crucial role


Competitive Intelligence

  • Arriving at a competitive benchmarking by taking into account the top industry players in the same category.
  • Best practices of production which will minimize cost
  • Production capacity of the key players along with number of manufacturing plants and its presence in different countries of Asia-Pacific


Real time updates

  • Tracking and analyzing real time developments of key players in the market such as expansions, new product launches and other strategic initiatives that help to stay dynamic in the market
  • Periodic updates on the major trends impacting the market 

1 Introduction
1.1 Introduce the Market
1.2 Objective of the study
1.3 Market Definition and Scope of the study
1.3.1 Market Definition
1.3.2 Areas covered
1.3.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Secondary sources
1.5.2 Primary Sources
1.5.3 Market estimation methodology (Top-down, bottom-up, data triangulation.)
1.5.4 Macro indicators for the study
1.6 Assumptions
1.7 List of Acronyms


2 Market Overview

3 Omega 3 & structured lipids (Nutraceuticals)-Asia-Pacific, By Geographies
3.1 Omega 3 & structured lipids (Nutraceuticals)-Japan
3.1.1 Omega 3 & structured lipids (Nutraceuticals)-Japan, By MacroIndicators Omega 3 & structured lipids (Nutraceuticals)-Population Projection-Japan
3.2 Omega 3 & structured lipids (Nutraceuticals)-China
3.2.1 Omega 3 & structured lipids (Nutraceuticals)-China, By MacroIndicators Omega 3 & structured lipids (Nutraceuticals)-Population Projection-China
3.3 Omega 3 & structured lipids (Nutraceuticals)-Australia
3.3.1 Omega 3 & structured lipids (Nutraceuticals)-Australia, By MacroIndicators Omega 3 & structured lipids (Nutraceuticals)-Population Projection-Australia
3.4 Omega 3 & structured lipids (Nutraceuticals)-India
3.4.1 Omega 3 & structured lipids (Nutraceuticals)-India, By MacroIndicators Omega 3 & structured lipids (Nutraceuticals)-Population Projection-India
3.5 Omega 3 & structured lipids (Nutraceuticals)-Asia-Pacific - Asia - Other Geographies

Asia-Pacific Nutraceuticals Asia-Pacific Nutraceuticals
The Asia-Pacific Nutraceuticals market had been valued at $7,511.9 million in 2013, and is projected to reach $10,733 million by 2018, at a CAGR of 7.4%. Prebiotics, probiotics, amino acids, peptides & proteins, omega 3 & structured  lipids, phytochemicals & plant extracts, minerals, vitamins are the types of Nutraceuticals.
23 May 2014 $ 3500
Europe Nutraceuticals Europe Nutraceuticals
The Europe Nutraceuticals market was valued at $6,352.4 million in 2013, and is estimated to grow at an annual rate of  7.2% between 2013 and 2018, to reach a projected $8,985.9 million by 2018. The market for Europe Nutraceuticals can be segmented on the basis of applications, regions, and types.
22 May 2014 $ 3500
North America Nutraceuticals North America Nutraceuticals
The North American market for nutraceuticals was valued at $6.2 billion in 2013, and is projected to reach $8.8 billion by 2018, at a CAGR of 7.0%. The North American market comprises prebiotics, probiotics, amino acids, peptides, proteins, minerals, vitamins, fibers, and speciality carbohydrates.
23 May 2014 $ 3500
of items
reports | Show